Differential beta-adrenoblocker therapy in chronic heart failure
Optimal pharmacotherapy of chronic heart failure (CHF) is essential for clinical outcome improvement. Recently, beta-adrenoblockers (BAB) have been regarded as first-line medications in CHD management. At the same time, their significant heterogeneity points to the need of differential administratio...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1604 |
| _version_ | 1797882819200942080 |
|---|---|
| author | S. N. Tereshchenko A. V. Anikina I. V. Zhirov E. A. Kotaeva |
| author_facet | S. N. Tereshchenko A. V. Anikina I. V. Zhirov E. A. Kotaeva |
| author_sort | S. N. Tereshchenko |
| collection | DOAJ |
| description | Optimal pharmacotherapy of chronic heart failure (CHF) is essential for clinical outcome improvement. Recently, beta-adrenoblockers (BAB) have been regarded as first-line medications in CHD management. At the same time, their significant heterogeneity points to the need of differential administration, taking into account individual clinical features. The benefits of therapy with nebivolol, a BAB with vasodilatator activity, in most CHF patients are demonstrated. |
| first_indexed | 2024-04-10T03:41:47Z |
| format | Article |
| id | doaj.art-8b7684a1a2be4bc38f568379420f409e |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:41:47Z |
| publishDate | 1970-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-8b7684a1a2be4bc38f568379420f409e2023-03-13T07:23:10Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-016893981321Differential beta-adrenoblocker therapy in chronic heart failureS. N. Tereshchenko0A. V. Anikina1I. V. Zhirov2E. A. Kotaeva3Московский государственный медико-стоматологический университет, МоскваМосковский государственный медико-стоматологический университет, МоскваМосковский государственный медико-стоматологический университет, МоскваМосковский государственный медико-стоматологический университет, МоскваOptimal pharmacotherapy of chronic heart failure (CHF) is essential for clinical outcome improvement. Recently, beta-adrenoblockers (BAB) have been regarded as first-line medications in CHD management. At the same time, their significant heterogeneity points to the need of differential administration, taking into account individual clinical features. The benefits of therapy with nebivolol, a BAB with vasodilatator activity, in most CHF patients are demonstrated.https://cardiovascular.elpub.ru/jour/article/view/1604хроническая сердечная недостаточностьβ-адреноблокаторынебиволол |
| spellingShingle | S. N. Tereshchenko A. V. Anikina I. V. Zhirov E. A. Kotaeva Differential beta-adrenoblocker therapy in chronic heart failure Кардиоваскулярная терапия и профилактика хроническая сердечная недостаточность β-адреноблокаторы небиволол |
| title | Differential beta-adrenoblocker therapy in chronic heart failure |
| title_full | Differential beta-adrenoblocker therapy in chronic heart failure |
| title_fullStr | Differential beta-adrenoblocker therapy in chronic heart failure |
| title_full_unstemmed | Differential beta-adrenoblocker therapy in chronic heart failure |
| title_short | Differential beta-adrenoblocker therapy in chronic heart failure |
| title_sort | differential beta adrenoblocker therapy in chronic heart failure |
| topic | хроническая сердечная недостаточность β-адреноблокаторы небиволол |
| url | https://cardiovascular.elpub.ru/jour/article/view/1604 |
| work_keys_str_mv | AT sntereshchenko differentialbetaadrenoblockertherapyinchronicheartfailure AT avanikina differentialbetaadrenoblockertherapyinchronicheartfailure AT ivzhirov differentialbetaadrenoblockertherapyinchronicheartfailure AT eakotaeva differentialbetaadrenoblockertherapyinchronicheartfailure |